Ara-C, Idarubicine and Gentuzumab Ozogamicin (AIM) as Salvage Treatment in Advanced Acute Myeloid Leukemia Patients.
Capria S, Trisolini SM, Minotti C, Stefanizzi C, Cardarelli L, Cartoni C, Diverio D, De Propris MS, Mancini M, Micozzi A, Foà R, Meloni G.
Capria S, et al. Among authors: de propris ms.
Mediterr J Hematol Infect Dis. 2012;4(1):e2012072. doi: 10.4084/MJHID.2012.072. Epub 2012 Nov 6.
Mediterr J Hematol Infect Dis. 2012.
PMID: 23205260
Free PMC article.